Targeting the glucagon receptor signaling pathway as a novel strategy to counteract PI3K inhibitor induced hyperglycemia while sustaining tumor PI3K inhibition.
Publication
, Journal Article
Wang, J; Osada, T; Morse, MA; Calzone, F; Yan, H; Thai, D; Lyerly, HK
Published in: Leuk Lymphoma
July 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
July 2021
Volume
62
Issue
7
Start / End Page
1761 / 1764
Location
United States
Related Subject Headings
- Signal Transduction
- Receptors, Glucagon
- Phosphatidylinositol 3-Kinases
- Neoplasms
- Immunology
- Hyperglycemia
- Humans
- Glucagon
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wang, J., Osada, T., Morse, M. A., Calzone, F., Yan, H., Thai, D., & Lyerly, H. K. (2021). Targeting the glucagon receptor signaling pathway as a novel strategy to counteract PI3K inhibitor induced hyperglycemia while sustaining tumor PI3K inhibition. Leuk Lymphoma, 62(7), 1761–1764. https://doi.org/10.1080/10428194.2021.1881504
Wang, Jie, Takuya Osada, Michael A. Morse, Frank Calzone, Hai Yan, Dung Thai, and H Kim Lyerly. “Targeting the glucagon receptor signaling pathway as a novel strategy to counteract PI3K inhibitor induced hyperglycemia while sustaining tumor PI3K inhibition.” Leuk Lymphoma 62, no. 7 (July 2021): 1761–64. https://doi.org/10.1080/10428194.2021.1881504.
Wang J, Osada T, Morse MA, Calzone F, Yan H, Thai D, et al. Targeting the glucagon receptor signaling pathway as a novel strategy to counteract PI3K inhibitor induced hyperglycemia while sustaining tumor PI3K inhibition. Leuk Lymphoma. 2021 Jul;62(7):1761–4.
Wang, Jie, et al. “Targeting the glucagon receptor signaling pathway as a novel strategy to counteract PI3K inhibitor induced hyperglycemia while sustaining tumor PI3K inhibition.” Leuk Lymphoma, vol. 62, no. 7, July 2021, pp. 1761–64. Pubmed, doi:10.1080/10428194.2021.1881504.
Wang J, Osada T, Morse MA, Calzone F, Yan H, Thai D, Lyerly HK. Targeting the glucagon receptor signaling pathway as a novel strategy to counteract PI3K inhibitor induced hyperglycemia while sustaining tumor PI3K inhibition. Leuk Lymphoma. 2021 Jul;62(7):1761–1764.
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
July 2021
Volume
62
Issue
7
Start / End Page
1761 / 1764
Location
United States
Related Subject Headings
- Signal Transduction
- Receptors, Glucagon
- Phosphatidylinositol 3-Kinases
- Neoplasms
- Immunology
- Hyperglycemia
- Humans
- Glucagon
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences